{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:19:20Z","timestamp":1775197160396,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2013\/08135-2"],"award-info":[{"award-number":["2013\/08135-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2017\/23117-1"],"award-info":[{"award-number":["2017\/23117-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2015\/09228-0"],"award-info":[{"award-number":["2015\/09228-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405918\/2022-4"],"award-info":[{"award-number":["405918\/2022-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303914\/2021-1"],"award-info":[{"award-number":["303914\/2021-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465539\/2014-9"],"award-info":[{"award-number":["465539\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["\/R007608\/1"],"award-info":[{"award-number":["\/R007608\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R007608\/1"],"award-info":[{"award-number":["MR\/R007608\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"Universitair Medisch Centrum Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xcrm.2025.102540","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:37:38Z","timestamp":1767886658000},"page":"102540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u0394Np73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia"],"prefix":"10.1016","volume":"7","author":[{"given":"Diego A.","family":"Pereira-Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Weinh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albertus T.J.","family":"Wierenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"van den Boom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Mojallali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Sternadt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha K.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanna M.","family":"Hogeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago M.","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prodromos","family":"Chatzikyriakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas R.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Ammatuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio R.","family":"Lucena-Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Quek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerwin","family":"Huls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo M.","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8452-8555","authenticated-orcid":false,"given":"Jan Jacob","family":"Schuringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102540_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102540_bib2","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.2024023840","article-title":"Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion","volume":"144","author":"Montoro","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102540_bib3","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2021014472","article-title":"Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"139","author":"Grob","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102540_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102540_bib5","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41591-020-1089-8","article-title":"Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial","volume":"26","author":"Burd","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102540_bib6","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/bjh.19472","article-title":"A 4-gene prognostic index for enhancing acute myeloid leukaemia survival prediction","volume":"204","author":"Ortiz Rojas","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2025.102540_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.737735","article-title":"Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond","volume":"9","author":"Logotheti","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2025.102540_bib8","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/sj.leu.2403483","article-title":"Analysis of p73 expression pattern in acute myeloid leukemias: lack of DeltaN-p73 expression is a frequent feature of acute promyelocytic leukemia","volume":"18","author":"Rizzo","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.102540_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.cdd.4400995","article-title":"Role of p73 in malignancy: Tumor suppressor or oncogene?","volume":"9","author":"Stiewe","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2025.102540_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2141.2008.07160.x","article-title":"The expression of \u0394nTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity","volume":"142","author":"Lucena-Araujo","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2025.102540_bib11","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1101\/gad.1695308","article-title":"TAp73 knockout shows genomic instability with infertility and tumor suppressor functions","volume":"22","author":"Tomasini","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2025.102540_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1101\/gad.1873910","article-title":"Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway","volume":"24","author":"Wilhelm","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2025.102540_bib13","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102540_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102540_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102540_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3324\/haematol.13299","article-title":"Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling","volume":"94","author":"Verhaak","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2025.102540_bib17","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2010-03-270991","article-title":"High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia","volume":"116","author":"de Jonge","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102540_bib18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102540_bib19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41467-022-28737-3","article-title":"The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia","volume":"13","author":"Erdem","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102540_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2018.08.014","article-title":"Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones","volume":"34","author":"de Boer","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102540_bib21","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/s41467-022-29639-0","article-title":"Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability","volume":"13","author":"Erdem","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102540_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102540_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative Proteomics of the Cancer Cell Line Encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102540_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41375-022-01744-5","article-title":"Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia","volume":"37","author":"Adamo","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.102540_bib25","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1182\/bloodadvances.2020002512","article-title":"TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML","volume":"4","author":"Vadakekolathu","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2025.102540_bib26","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41375-022-01655-5","article-title":"Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia","volume":"36","author":"Ong","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.102540_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100864","article-title":"CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclones","volume":"2","author":"Houtsma","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2025.102540_bib28","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1182\/bloodadvances.2021005018","article-title":"CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones","volume":"6","author":"Houtsma","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2025.102540_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.aax3649","article-title":"A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies","volume":"365","author":"Boettcher","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102540_bib30","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/s41467-023-37381-4","article-title":"Targeting C\/EBP\u03b1 overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102540_bib31","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/2159-8290.CD-22-0411","article-title":"C\/EBP\u03b1 Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia","volume":"13","author":"Sabatier","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102540_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41420-024-02179-w","article-title":"C\/EBP\u03b1-mediated ACSL4-dependent ferroptosis exacerbates tubular injury in diabetic kidney disease","volume":"10","author":"Xia","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.xcrm.2025.102540_bib33","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.stem.2021.06.004","article-title":"Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis","volume":"28","author":"Subedi","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2025.102540_bib34","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1021\/jm200319u","article-title":"Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia","volume":"54","author":"Oballa","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.xcrm.2025.102540_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2025.102540_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10585-022-10189-0","article-title":"Resistance to targeted therapies in acute myeloid leukemia","volume":"40","author":"Mecklenbrauck","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.xcrm.2025.102540_bib37","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/2159-8290.CD-19-1008","article-title":"Extracellular ATP and CD39 Activate cAMP-Mediated Mitochondrial Stress Response to Promote Cytarabine Resistance in Acute Myeloid Leukemia","volume":"10","author":"Aroua","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102540_bib38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102540_bib39","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1158\/0008-5472.CAN-23-1006","article-title":"Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold","volume":"83","author":"Griessinger","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102540_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2020.06.003","article-title":"AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy","volume":"87","author":"Yan","year":"2020","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.xcrm.2025.102540_bib41","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.2024025409","article-title":"Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations","volume":"144","author":"D\u00f6hner","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102540_bib42","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1200\/JCO.23.02631","article-title":"Risk Stratification in Older Intensively Treated Patients With AML","volume":"42","author":"Versluis","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102540_bib43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41408-024-01061-3","article-title":"Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis","volume":"14","author":"Lee","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2025.102540_bib44","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s41588-023-01480-1","article-title":"Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution","volume":"55","author":"Rodriguez-Meira","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102540_bib45","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41419-018-1042-7","article-title":"A new signaling cascade linking BMP4, BMPR1A, \u0394Np73 and NANOG impacts on stem-like human cell properties and patient outcome","volume":"9","author":"Voeltzel","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2025.102540_bib46","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2015-01-623330","article-title":"High \u0394np73\/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia","volume":"126","author":"Lucena-Araujo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102540_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-024-01086-8","article-title":"Prognostic implications of \u0394Np73\/TAp73 expression ratio in core-binding factor acute myeloid leukemia","volume":"14","author":"Salustiano-Bandeira","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2025.102540_bib48","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1182\/blood.2019000239","article-title":"Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia","volume":"134","author":"Lucena-Araujo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102540_bib49","first-page":"917","article-title":"[Ferroptosis, lipid metabolism, C\/EBP\u03b1 and therapeutic resistance in acute myeloid leukemia]","volume":"39","author":"Birsen","year":"2023","journal-title":"Med. Sci."},{"key":"10.1016\/j.xcrm.2025.102540_bib50","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41375-024-02390-9","article-title":"Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation","volume":"38","author":"Dembitz","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.102540_bib51","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102540_bib52","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.22.00181","article-title":"Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"40","author":"Mishra","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102540_bib53","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S2352-3026(22)00403-3","article-title":"Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study","volume":"10","author":"Garcia-Manero","year":"2023","journal-title":"Lancet. Haematol."},{"key":"10.1016\/j.xcrm.2025.102540_bib54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/01.CIR.0000154607.90506.45","article-title":"Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates","volume":"111","author":"Weyrich","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2025.102540_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051003","article-title":"The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia","volume":"13","author":"Gaidano","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2025.102540_bib56","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.18632\/oncotarget.14295","article-title":"\u0394Np73 overexpression promotes resistance to apoptosis but does not cooperate with PML\/RARA in the induction of an APL-leukemic phenotype","volume":"8","author":"Lucena-Araujo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2025.102540_bib57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102540_bib58","doi-asserted-by":"crossref","first-page":"W158","DOI":"10.1093\/nar\/gkz348","article-title":"WashU Epigenome Browser update 2019","volume":"47","author":"Li","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102540_bib59","doi-asserted-by":"crossref","unstructured":"Lachmann, A., Xie, Z., and Ma\u2019ayan, A. (2018). Elysium: RNA-seq Alignment in the Cloud, https:\/\/doi.org\/10.1101\/382937https:\/\/doi.org\/10.1101\/382937.","DOI":"10.1101\/382937"},{"key":"10.1016\/j.xcrm.2025.102540_bib60","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102540_bib61","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102540_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102540_bib63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102540_bib64","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102540_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2025.102540_bib66","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102540_bib67","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102540_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf8522","article-title":"M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism","volume":"9","author":"Weinh\u00e4user","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102540_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102540_bib70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41419-021-03604-z","article-title":"MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model","volume":"12","author":"Pereira-Martins","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2025.102540_bib71","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.celrep.2015.12.034","article-title":"Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis","volume":"14","author":"van den Boom","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102540_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102435","article-title":"The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia","volume":"24","author":"Maat","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2025.102540_bib73","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41392-025-02303-x","article-title":"High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability","volume":"10","author":"Pereira-Martins","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102540_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/bloodadvances.2023010786","article-title":"The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia","volume":"8","author":"Cunningham","year":"2024","journal-title":"Blood Adv."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125006135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125006135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:19:35Z","timestamp":1775189975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125006135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666379125006135"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102540","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u0394Np73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102540"}}